Walleye Capital
CNMD icon

Walleye Capital’s CONMED CNMD Stock Holding History

Walleye Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-56,427
Closed -$5.69M – 5003
2023
Q3 		$5.69M Buy
+56,427
New +$6.48M 0.01% 935
2021
Q2 		– Sell
-7,169
Closed -$936 – 1365
2021
Q1 		$936 Buy
+7,169
New +$863K 0.05% 322
2020
Q4 		– Sell
-4,803
Closed -$378K – 962
2020
Q3 		$378K Buy
4,803
+1,721
+56% +$140K 0.04% 450
2020
Q2 		$222K Buy
+3,082
New +$214K 0.05% 403

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Walleye Capital's CNMD Position: Q4 2023 in Review

Walleye Capital sold out of CONMED (CNMD) in Q4 2023, closing a stake of 56,427 shares — an estimated $5.69M sold.

Walleye Capital first reported a position in CNMD in Q2 2020 and held it in 4 quarters. The position peaked at $5.69M in Q3 2023. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

  • Walleye Capital reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 56,427 CONMED shares in Q4 2023, an estimated $5.69M.
  • Walleye Capital first reported a position in CONMED in Q2 2020 and held it in 4 quarters.
  • Walleye Capital's CONMED position peaked at $5.69M in Q3 2023.
  • 306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.